Dosimetry in Peptide radionuclide receptor therapy: a review.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16954555.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The potential of targeted therapy with radiolabeled peptides has been reported in several clinical trials. Although there have been many improvements in dose estimation, a general and reliable dosimetric approach in peptide receptor radionuclide therapy (PRRT) is still a matter of debate. This article reviews the methods for PRRT dosimetry and the results presented in the literature. Radiopharmaceutical characteristics, data processing, dosimetric outcomes, and methods to protect critical organs are reported. The biological effective dose, based on the linear quadratic model, is also described.
Medical subject headings
- Models, Biological
- Neoplasms
- Peptides
- Radioisotopes
- Radiometry
- Radiotherapy Planning, Computer-Assisted